FDA Grants First-Ever EUA for Treating New World S...
Category : Approval/Launch 22 November 2025The U.S. FDA has issued a historic Emergency Use Authorization (EUA) for Elanco’s Credelio&tra...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Eli Lilly Joins the $1 Trillion Club: How Weight-L...
Category : Product Related Updates 22 November 2025Eli Lilly has officially crossed the $1 trillion market value mark, becoming the first drugmaker in...
Merck Announces Positive Phase 3 Results for Two-D...
Category : Clinical Trial Update 21 November 2025Merck (known as MSD outside the U.S. and Canada) has reported encouraging topline results from a piv...
Viking Therapeutics Completes Enrollment for Phase...
Category : Clinical Trial Update 21 November 2025Viking Therapeutics has reached an important milestone in its obesity drug pipeline. The company ann...
New TB Trial Data Shows Sorfequiline Could Dramati...
Category : Clinical Trial Update 21 November 2025A major breakthrough in tuberculosis (TB) drug development is emerging. New phase 2 clinical trial r...
Latest Newsletter Post
-
Eli Lilly Joins the $1 Trillion Clu..
22 November 2025
-
FDA Grants First-Ever EUA for Treat..
22 November 2025
-
Theravance Biopharma Announces Virt..
21 November 2025
-
New TB Trial Data Shows Sorfequilin..
21 November 2025
-
Viking Therapeutics Completes Enrol..
21 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com